Recombitek Equine West Nile Virus (Canada) Drug Information and side effects
Or click the first letter of a drug name: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
close :

:

Forgotten your password?

Veterinary Product Information

Print Print   
Vet > Recombitek Equine West Nile Virus (Canada)

Recombitek Equine West Nile Virus (Canada)

This page contains information on Recombitek Equine West Nile Virus for veterinary use.
The information provided typically includes the following:
  • Recombitek Equine West Nile Virus Indications
  • Warnings and cautions for Recombitek Equine West Nile Virus
  • Direction and dosage information for Recombitek Equine West Nile Virus

Recombitek Equine West Nile Virus

This treatment applies to the following species:
Manufacturer: Merial

West Nile Virus Vaccine, Live Canarypox Vector

Description

Contents

RECOMBITEK® Equine West Nile Virus contains a lyophilized recombinant canarypox vectored West Nile Virus vaccine plus a sterile liquid diluent. A canarypox vector has been modified using recombinant technology to express the desired antigens capable of stimulating a protective immune response to West Nile Virus. After inoculation, the vector does not multiply in the horse, but does express the protective proteins. As a consequence, these components induce an immune status against West Nile Virus. Safety and immunogenicity of this vaccine have been demonstrated by vaccination and challenge tests in susceptible horses.

Recombitek Equine West Nile Virus Indications

Recombitek® WNV is recommended for the vaccination of healthy horses as an aid in the prevention of viremia due to West Nile Virus infection.

Dosage

Reconstitute the lyophilized vaccine with accompanying liquid diluent and aseptically inject a 1 ml dose by intramuscular route. For primary vaccination, revaccinate with a second 1 ml dose of this product 4 to 6 weeks later. Annual revaccination with a single dose is recommended.

Precautions

Store at 2-7C (35-45F). For the preparation and administration of the vaccine, use sterile and antiseptic-free and/or disinfectant-free material. Burn container and all unused contents. Contains gentamicin as a preservative. Do not vaccinate within 21 days prior to slaughter. As with any vaccine, a hypersensitivity reaction may occur, which may require appropriate symptomatic treatment.

SOLD TO VETERNARIANS ONLY.

For Veterinary Use Only.

Manufactured By: MERIAL, INC., Athens, GA 30601 USA

U.S. Vet. Lic. No. 298

1-888-Merial-1 (1-888-637-4251)

Distributed In Canada By: MERIAL CANADA, INC., Baie d'Urfé, Qc H9X 4B6

RECOMBITEK is a registered trademark of MERIAL.

Contains

 

Prod. No.

 

10 Doses

10 x 1 dose (1 mL)

10 x 1 Dose, Lyophilized

10 x 1 mL, Sterile Diluent

2418-10

RM410R3

25 Doses

5 x 5 dose (5 mL)

5 x 5 Dose, Lyophilized

5 x 5 mL, Sterile Diluent

2418-05

RM1011R2

Nac No.

11821121
MERIAL CANADA INC.
20000 CLARK GRAHAM, BAIE D'URFÉ, QC, H9X 4B6
Telephone:   514-457-1555
Order Desk:   888-637-4251 (888-MERIAL1)
Fax:   514-457-1175
Website:   www.merial.com
Email:   service.canada@merial.com
Every effort has been made to ensure the accuracy of the Recombitek Equine West Nile Virus information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the Recombitek Equine West Nile Virus product label or package insert.



Join Drugs.com
Click here to see what benefits you can get by joining our FREE membership programme.
Drugs.com is the most popular, comprehensive, and up-to-date source of drug information online. Providing advice on more than 24,000 prescription drugs and over-the-counter medicines for consumers and professionals .
Advertisement